Spots Global Cancer Trial Database for A Phase I Trial of ZIO-101 in Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase I Trial of ZIO-101 in Solid Tumors
Official Title: A Phase I Trial of ZIO-101 in Solid Tumors: Protocol # SGL1002
Study ID: NCT00591396
Conditions
Solid Tumors
Interventions
ZIO-101 (Darinaparsin)
Study Description
Brief Summary: A Phase I Trial of ZIO-101 (Darinaparsin) in Solid Tumors
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Houston, Texas, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
